Stephen V Liu, Director of Thoracic Oncology, Chief, Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on X:
“Comparison of EGFR NSCLC transformed to SCLC vs de novo SCLC. OS shorter with transformed SCLC esp with high neuroendocrine marker expression. In transformed SCLC, OS with chemo-immunotherapy superior to chemo +/- TKI (15.4m vs 8.5m).”
Title: Clinical outcomes and neuroendocrine features of transformed versus primary small-cell lung cancer
Authors: Lina Chen, Xiu-Hao Zhang, Zi-Ji Mao, Dan Wang, Chan-Yuan Zhang, Hua-Jun Chen, Yi-Long Wu, Jin-Ji Yang
Read the Full Article.
More posts featuring Stephen Liu.